GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » Cash Flow for Dividends

Ebos Group (ASX:EBO) Cash Flow for Dividends : A$-197 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Ebos Group Cash Flow for Dividends?

Ebos Group's cash flow for dividends for the six months ended in Dec. 2023 was A$-102 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was A$-197 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Ebos Group's quarterly payment of dividends increased from Dec. 2022 (A$-82 Mil) to Jun. 2023 (A$-95 Mil) and increased from Jun. 2023 (A$-95 Mil) to Dec. 2023 (A$-102 Mil).

Ebos Group's annual payment of dividends increased from Jun. 2021 (A$-125 Mil) to Jun. 2022 (A$-154 Mil) and increased from Jun. 2022 (A$-154 Mil) to Jun. 2023 (A$-175 Mil).


Ebos Group Cash Flow for Dividends Historical Data

The historical data trend for Ebos Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Cash Flow for Dividends Chart

Ebos Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -99.38 -111.83 -124.84 -154.48 -174.81

Ebos Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.54 -85.33 -82.26 -94.95 -101.80

Ebos Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-197 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ebos Group Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Ebos Group's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Ebos Group (ASX:EBO) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines